FIELD: chemistry.
SUBSTANCE: invention relates to compounds of formula
, where R1 denotes a lower alkyl; R2 denotes phenyl or a 5- or 6-member heteroaryl containing 1-2 N atoms or 1 N atom and 1 S atom as heteroatoms, which may be unsubstituted or substituted with a substitute selected from halogen or lower alkyl; R3 denotes hydrogen, phenyl or a 5-6-member heteroaryl containing 1-2 N atoms and 1 O atom as heteroatoms, which can be unsubstituted or substituted with a substitute selected from 1-2 halogen atoms, lower alkyl or a S(O)2-lower alkyl group; as well as pharmaceutically acceptable salts thereof. The invention also relates to a pharmaceutical composition, having metabotropic glutamate receptor mGluR5 antagonist properties, which contains the compound of formula (I) as active component and pharmaceutically acceptable excipients.
EFFECT: possibility of using said derivatives as mGluR5 receptor antagonists.
25 cl, 2 dwg, 1 tbl, 30 ex
Title | Year | Author | Number |
---|---|---|---|
NAPHTHYRIDINE DERIVATIVES | 2006 |
|
RU2418799C2 |
PYRAZINE-2-CARBOXAMIDE DERIVATIVES AS mGluR5 ANTAGONISTS | 2006 |
|
RU2407739C2 |
PYRIDINE-2-CARBOXAMIDE DERIVATIVES AS mGluR5 ANTAGONISTS | 2006 |
|
RU2411237C2 |
3-OXO-3,9-DIHYDRO-1H-CHROMENO[2,3-c] PYRROLES AS GLUCOKINASE ACTIVATORS | 2011 |
|
RU2603191C2 |
NITROGEN-CONTAINING HETEROARYL DERIVATIVES | 2011 |
|
RU2559895C2 |
DIHYDROOXAZOLE-2-AMINE DERIVATIVES | 2011 |
|
RU2587512C2 |
POSITIVE ALLOSTERIC MODULATORS (PAM) | 2010 |
|
RU2561920C2 |
PYRAZOLPYRIMIDINE DERIVATIVES | 2005 |
|
RU2378277C2 |
IMIDAZOPYRAZINES | 2012 |
|
RU2600327C2 |
IMIDAZO[1,2-A]PYRIDIN-7-AMINES AS IMAGING TOOLS | 2014 |
|
RU2671506C2 |
Authors
Dates
2011-08-10—Published
2006-10-26—Filed